Aziz Kabeer — SEC insider filings
SEC reporting owner CIK 1914847. 23 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2022-03-31 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 166,666 shares, $2,499,990 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 20 legs across 7 filings — 223,880 shares, $3,976,729 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: purchase of 166,666 shares @ $15.00 ($2,499,990) in AN2 Therapeutics, Inc., filed 2022-03-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | Director | 23 | 1 leg · 166,666 sh · $2,499,990 | 20 legs · 223,880 sh · $3,976,729 | 27 |
Insider filings — Aziz Kabeer
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 2,465 @ $0 | EDGAR |
| 2026-07-10 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 2,852 @ $0 | EDGAR |
| 2026-04-10 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 3,775 @ $0 | EDGAR |
| 2026-03-23 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 20,724 (derivative) · Disposition to issuer (D): 20,724 (derivative) · Grant/award (A): 23,742 (derivative) · Disposition to issuer (D): 23,742 (derivative) | EDGAR |
| 2026-02-23 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 11,560 @ $0 | EDGAR |
| 2025-10-14 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 10,367 @ $0 | EDGAR |
| 2025-07-11 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 11,875 @ $0 | EDGAR |
| 2025-05-23 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 19,111 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 9,705 @ $0 | EDGAR |
| 2024-12-23 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 8,972 @ $0 | EDGAR |
| 2024-06-21 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 64,503 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | AN2 Therapeutics, Inc. (ANTX) | Sale (S): 84,093 @ $19.65 · Sale (S): 15,907 @ $19.65 | EDGAR |
| 2023-11-16 | 4 | AN2 Therapeutics, Inc. (ANTX) | Sale (S): 1,522 @ $16.15 · Sale (S): 288 @ $16.15 | EDGAR |
| 2023-10-03 | 4 | AN2 Therapeutics, Inc. (ANTX) | Sale (S): 83,337 @ $16.28 · Sale (S): 15,764 @ $16.28 · Sale (S): 4,770 @ $16.07 · Sale (S): 902 @ $16.07 | EDGAR |
| 2023-09-29 | 4 | AN2 Therapeutics, Inc. (ANTX) | Sale (S): 707 @ $16.07 · Sale (S): 134 @ $16.07 · Sale (S): 7,160 @ $16.11 · Sale (S): 1,356 @ $16.11 | EDGAR |
| 2023-09-15 | 4 | AN2 Therapeutics, Inc. (ANTX) | Sale (S): 336 @ $16 · Sale (S): 64 @ $16 | EDGAR |
| 2023-09-08 | 4 | AN2 Therapeutics, Inc. (ANTX) | Sale (S): 3,164 @ $16.02 · Sale (S): 598 @ $16.02 · Sale (S): 2,841 @ $16.05 · Sale (S): 537 @ $16.05 | EDGAR |
| 2023-08-25 | 4 | AN2 Therapeutics, Inc. (ANTX) | Sale (S): 336 @ $16 · Sale (S): 64 @ $16 | EDGAR |
| 2023-06-09 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 23,742 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | AN2 Therapeutics, Inc. (ANTX) | Other (J): 26,511 @ $15 · Other (J): 26,511 @ $15 | EDGAR |
| 2022-05-16 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 20,724 (derivative) @ $0 | EDGAR |
| 2022-03-31 | 4 | AN2 Therapeutics, Inc. (ANTX) | Conversion (C): 1,651,636 · Conversion (C): 312,415 · Conversion (C): 392,433 · Conversion (C): 74,230 · Purchase (P): 166,666 @ $15 · Conversion (C): 1,651,636 (derivative) @ $0 · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-03-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1914847 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs